GENE 0.8 (-27.93%)
SE0000661613Medical Diagnostics & ResearchDiagnostics & Research

Genetic Technologies (GENE) Competitor Comparison

We are evaluating the key criteria listed to compare Genetic Technologies (GENE) against its competitors in the Diagnostics & Research industry.

Performance 3 years - GENE ranking 0 / 58

These are the competitors of Genetic Technologies in the industry Diagnostics & Research ranked by performance 3 years
1. Lantheus Holdings LNTH
356.77
2. Meridian Bioscience VIVO
246.63
3. Medpace Holdings MEDP
140.94
4. RadNet RDNT
75.81
5. Icon ICLR
59.06
6. Heska HSKA
41.31
7. Trinity Biotech TRIB
36.51
8. PerkinElmer PKI
21.19
9. Ortho Clinical Diagnostics Holdings OCDX
13.74
10. Quest Diagnostics DGX
6.75
11. Thermo Fisher Scientific TMO
5.46
12. DexCom DXCM
2.42
13. Danaher DHR
-0.13
14. Mettler-Toledo MTD
-5.54
15. Natera NTRA
-8.35
16. IQVIA Holdings IQV
-10.91
17. Agilent Technologies A
-12.23
18. Laboratory Corp of America Holdings LH
-14.76
19. Qiagen QGEN
-17.63
20. Waters WAT
-18.27
21. Syneos Health SYNH
-19.01
22. Myriad Genetics MYGN
-20.76
23. Olink Holding OLK
-22.2
24. IDEXX Laboratories IDXX
-25.53
25. Anixa Biosciences ANIX
-27.49
26. Charles River Laboratories CRL
-43.85
27. Sotera Health SHC
-48.59
28. National Research NRC
-50.61
29. Sera Prognostics SERA
-57.76
30. Twist Bioscience TWST
-58.76
31. Bioventus BVS
-59.74
32. Exact Sciences EXAS
-61.33
33. Enzo Biochem ENZ
-62.94
34. Neogen NEOG
-63.49
35. Psychemedics PMD
-65.5
36. Global Cord Blood CO
-67.25
37. NeoGenomics NEO
-67.34
38. bioAffinity Technologies BIAF
-69.52
39. MaxCyte MXCT
-73.57
40. Guardant Health GH
-75
41. Illumina ILMN
-75.81
42. Fulgent Genetics FLGT
-76.47
43. MDxHealth MDXH
-77.04
44. CareDx CDNA
-81.9
45. Co-Diagnostics CODX
-83.35
46. Biodesix BDSX
-85.96
47. Exagen XGN
-86.69
48. Neuronetics STIM
-87.1
49. Interpace Biosciences IDXG
-89.18
50. Organovo Holdings ONVO
-89.19
51. Inotiv NOTV
-92.13
52. DarioHealth DRIO
-92.43
53. Personalis PSNL
-93.08
54. Precipio PRPO
-93.18
55. Prenetics Global PRE
-94.37
56. Pacific Biosciences of California PACB
-94.77
57. SeqLL SQL
-95.1
58. Aspira Womens Health AWH
-98.83

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.